Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 709 of 1,261
  1. US 9260510

    Pertussis antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  2. US 9260504

    N- and C-terminal substituted antagonistic analogs of GH-RH

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  3. US 9260493

    Transducible delivery of nucleic acids using modified dsRNA binding domains

    The Regents of the University of California · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  4. US 9260446

    Synthetic methods for spiro-oxindole compounds

    Xenon Pharmaceuticals Inc. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  5. US 9260500

    Peptide and use thereof

    Takeda Pharmaceutical Company Limited · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  6. US 9260414

    Inhibitors of hepatitic C virus

    Theravance Biopharma R&D IP, LLC · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  7. US 9259488

    Anti-C3d antibody conjugates and methods of detecting complement activation

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  8. US 9259510

    System and method for forming bone, ligament, and bone-ligament constructs

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  9. US 9259473

    Polymer hydrogel adhesives formed with multiple crosslinking mechanisms at physiologic pH

    Northwestern University · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  10. US 9259465

    Methods and compositions for inhibiting diseases of the central nervous system

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  11. US 9260371

    Compositions and methods for modification of biomolecules

    The Regents of the University of California · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  12. US 9259456

    Methods and compositions for oral administration of proteins

    Oramed Pharmaceuticals Inc. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  13. WO 2016020210

    ...

    CSL BEHRING GMBH [DE] · Granted Feb 11, 2016 · Expires Feb 6, 2036

    granted
  14. US 9254339

    Protein-polymer-drug conjugates

    Mersana Therapeutics, Inc. · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted
  15. US 9255076

    Arylpiperazine derivatives and methods of utilizing same

    REVIVA PHARMACEUTICALS, INC. · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted
  16. US 9254316

    Adenoviral vector-based malaria vaccines

    United States of America as represented by the Secretary of the Air Force · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted
  17. US 9254262

    Dosage and formulation

    Almirall, S.A. · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted
  18. US 9254338

    Use of a VEGF antagonist to treat angiogenic eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted
  19. US 9254310

    Therapeutic and cosmetic uses and applications of calreticulin

    CALREGEN INC. · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted
  20. US 9254319

    Compositions and methods for generating an immune response

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted
  21. US 9255260

    Cytotoxic ribonuclease variants

    The Regents of the University of California · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted
  22. US 9254274

    Method of treating Tourette'S disorder with GABA-aminotransferase inactivators

    Catalyst Pharmaceuticals, Inc. · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted
  23. US 9254291

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted
  24. US 9255250

    Isolated mouse or human cell having an exogenous transgene in an endogenous albumin gene

    Sangamo Biosciences, Inc. · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.